Jane Yu

5.8k total citations
74 papers, 3.7k citations indexed

About

Jane Yu is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Jane Yu has authored 74 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Physiology, 40 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Jane Yu's work include Tuberous Sclerosis Complex Research (44 papers), Eosinophilic Disorders and Syndromes (12 papers) and Renal and related cancers (11 papers). Jane Yu is often cited by papers focused on Tuberous Sclerosis Complex Research (44 papers), Eosinophilic Disorders and Syndromes (12 papers) and Renal and related cancers (11 papers). Jane Yu collaborates with scholars based in United States, China and United Kingdom. Jane Yu's co-authors include Elizabeth P. Henske, Aristotelis Astrinidis, Andrey A. Parkhitko, Tasha Morrison, Magdalena Karbowniczek, John Blenis, Chenggang Li, Lewis C. Cantley, Jamie M. Dempsey and Donna Spiegelman and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Jane Yu

68 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Yu United States 31 1.6k 1.5k 847 711 620 74 3.7k
Hong Yang China 30 1.6k 1.0× 820 0.6× 349 0.4× 404 0.6× 749 1.2× 177 3.5k
Virginia Kaklamani United States 42 1.6k 1.0× 636 0.4× 2.1k 2.5× 943 1.3× 958 1.5× 176 5.2k
Kristin M. Nieman United States 19 1.9k 1.2× 521 0.4× 981 1.2× 396 0.6× 1.7k 2.7× 42 4.0k
Li Cai China 32 1.7k 1.0× 338 0.2× 807 1.0× 524 0.7× 802 1.3× 159 3.3k
Scott Turner United States 39 1.7k 1.0× 1.3k 0.9× 369 0.4× 347 0.5× 416 0.7× 122 4.8k
Yasunori Fujita Japan 34 2.0k 1.2× 617 0.4× 335 0.4× 280 0.4× 1.1k 1.8× 105 3.8k
Benjamin D. Hopkins United States 26 3.0k 1.8× 485 0.3× 979 1.2× 576 0.8× 940 1.5× 44 4.5k
Robert McCormack United States 18 1.2k 0.7× 1.4k 0.9× 806 1.0× 711 1.0× 675 1.1× 39 3.1k
Shiying Yu China 31 1.5k 0.9× 496 0.3× 1.3k 1.6× 926 1.3× 870 1.4× 141 3.7k
Cullen M. Taniguchi United States 25 2.8k 1.7× 1.6k 1.1× 939 1.1× 577 0.8× 962 1.6× 128 5.9k

Countries citing papers authored by Jane Yu

Since Specialization
Citations

This map shows the geographic impact of Jane Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Yu more than expected).

Fields of papers citing papers by Jane Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Yu. The network helps show where Jane Yu may publish in the future.

Co-authorship network of co-authors of Jane Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Yu. A scholar is included among the top collaborators of Jane Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Yu. Jane Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner, Andrew, Aristotelis Astrinidis, Minzhe Guo, et al.. (2023). Single-cell multiomic analysis identifies a HOX-PBX gene network regulating the survival of lymphangioleiomyomatosis cells. Science Advances. 9(19). eadf8549–eadf8549. 6 indexed citations
2.
Dai, Lan, Jianfeng Huang, Lei Hu, et al.. (2023). Efficacy of Nimotuzumab plus Concurrent Chemo-Radiotherapy for Unresectable Esophageal Cancer: A Real-World Study. International Journal of Radiation Oncology*Biology*Physics. 117(2). e354–e354. 1 indexed citations
3.
Barone, Sharon, Kamyar Zahedi, L. Shannon Holliday, et al.. (2022). Identification of an Electrogenic 2Cl−/H+ Exchanger, ClC5, as a Chloride-Secreting Transporter Candidate in Kidney Cyst Epithelium in Tuberous Sclerosis. American Journal Of Pathology. 193(2). 191–200. 4 indexed citations
4.
Du, Yina, Minzhe Guo, Yixin Wu, et al.. (2022). Lymphangioleiomyomatosis (LAM) Cell Atlas. Thorax. 78(1). 85–87. 10 indexed citations
5.
Kosmas, Kosmas, Harilaos Filippakis, Damir Khabibullin, et al.. (2021). TSC2 Interacts with HDLBP/Vigilin and Regulates Stress Granule Formation. Molecular Cancer Research. 19(8). 1389–1397. 17 indexed citations
6.
Yu, Jane, et al.. (2021). Can ECIS Biosensor Technology Be Used to Measure the Cellular Responses of Glioblastoma Stem Cells?. Biosensors. 11(12). 498–498. 9 indexed citations
7.
Barone, Sharon, Kamyar Zahedi, Elizabeth P. Henske, et al.. (2021). Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex. Proceedings of the National Academy of Sciences. 118(6). 16 indexed citations
8.
Liu, Xiaolei, Erik Zhang, Elizabeth J. Kopras, et al.. (2020). Estrogen activates pyruvate kinase M2 and increases the growth of TSC2-deficient cells. PLoS ONE. 15(2). e0228894–e0228894. 14 indexed citations
9.
Guo, Minzhe, Jane Yu, Anne‐Karina T. Perl, et al.. (2020). Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell. American Journal of Respiratory and Critical Care Medicine. 202(10). 1373–1387. 55 indexed citations
10.
Li, Yang, Ying Dong, Yanjun Li, et al.. (2019). IL‐10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF‐κB/Notch1 pathway in non‐small cell lung cancer. International Journal of Cancer. 145(4). 1099–1110. 142 indexed citations
11.
Tang, Ling, Jun Zeng, Pengyu Geng, et al.. (2017). Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma. Clinical Cancer Research. 24(2). 474–485. 101 indexed citations
12.
Li, Jing, Sejeong Shin, Yang Sun, et al.. (2016). mTORC1-Driven Tumor Cells Are Highly Sensitive to Therapeutic Targeting by Antagonists of Oxidative Stress. Cancer Research. 76(16). 4816–4827. 20 indexed citations
13.
Manna, Subrata, Josefine Bostner, Yang Sun, et al.. (2015). ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer. Clinical Cancer Research. 22(6). 1421–1431. 51 indexed citations
14.
Medvetz, Doug, Yang Sun, Chenggang Li, et al.. (2014). High-Throughput Drug Screen Identifies Chelerythrine as a Selective Inducer of Death in a TSC2-null Setting. Molecular Cancer Research. 13(1). 50–62. 21 indexed citations
15.
Sun, Yangying, Xin Gu, Mi‐Ae Park, et al.. (2014). Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells. Cell Death and Disease. 5(5). e1231–e1231. 36 indexed citations
16.
Gu, Xiaoxiao, et al.. (2013). Integration of mTOR and estrogen–ERK2 signaling in lymphangioleiomyomatosis pathogenesis. Proceedings of the National Academy of Sciences. 110(37). 14960–14965. 55 indexed citations
17.
Parkhitko, Andrey A., Carmen Priolo, Jonathan L. Coloff, et al.. (2013). Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide. Molecular Cancer Research. 12(1). 48–57. 50 indexed citations
18.
Parkhitko, Andrey A., Tasha Morrison, K.M. Hindi, et al.. (2011). Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Proceedings of the National Academy of Sciences. 108(30). 12455–12460. 154 indexed citations
19.
Yu, Jane, Victoria A. Robb, Tasha Morrison, et al.. (2009). Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proceedings of the National Academy of Sciences. 106(8). 2635–2640. 122 indexed citations
20.
Yu, Jane, et al.. (2001). Chromosome 16 Loss of Heterozygosity in Tuberous Sclerosis and Sporadic Lymphangiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 164(8). 1537–1540. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Yang Breakdown of academic impact, for papers by Virginia Kaklamani Breakdown of academic impact, for papers by Kristin M. Nieman Breakdown of academic impact, for papers by Li Cai Breakdown of academic impact, for papers by Scott Turner Breakdown of academic impact, for papers by Yasunori Fujita Breakdown of academic impact, for papers by Benjamin D. Hopkins Breakdown of academic impact, for papers by Robert McCormack Breakdown of academic impact, for papers by Shiying Yu Breakdown of academic impact, for papers by Cullen M. Taniguchi
Rankless by CCL
2026